| Name | blinatuMoMab |
|---|
| Description | Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |